Stockscreener 앱 받기
3.02
1.69%
0.07
Aclarion Inc 주식(ACON)의 최신 뉴스
Aclarion Announces Texas Spine Care Center as New CLARITY Site - marketscreener.com
Aclarion adds Texas Spine Care Center to CLARITY trial - Investing.com
Aclarion adds Texas Spine Care Center to CLARITY trial By Investing.com - Investing.com Canada
Aclarion expands CLARITY trial with Texas spine center - Stock Titan
Aclarion, Inc. Warrant 2022- on Aclarion Financial Disclosures & SEC Filings - TradingView
ACON Q1 2026 Earnings: EPS Surpasses Analyst Estimates Despite Lack of Revenue DisclosureFull Year Guidance - dars.gov.et
Enterprise value to EBIT forward of Aclarion, Inc. – NASDAQ:ACON - TradingView
Price to book forward of Aclarion, Inc. – NASDAQ:ACON - TradingView
A412BH Forecast — Price Target — Prediction for 2027 - TradingView
Aclarion, Inc. Actuals & Estimates (NASDAQ:ACON) - TradingView
ACON Forecast — Price Target — Prediction for 2027 - TradingView
Aclarion Inc (ACONW) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Aclarion Inc. (ACON) Q1 2026 Earnings: EPS Surpasses Estimates with 15% Beat Despite No RevenueGAAP Earnings Report - dars.gov.et
Aclarion Inc (ACONW) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Aclarion Inc. Warrant (ACONW) Surges 38% From Penny Levels – But Caution WarrantedBPI Bull Correction - Město Břeclav
Aclarion Inc. Holds Steady Near Key Resistance Level (ACON)RTH Profile - dars.gov.et
Aclarion (ACON) upgraded to buy: Here's why - MSN
Aclarion Inc (ACONW) Valuation: PE, PB & Fair Value Analysis - TradingKey
Aclarion Inc (ACONW) Institutional Confidence - TradingKey
Aclarion Inc (ACONW) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Aclarion Inc (ACONW) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Aclarion Inc (ACONW) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Aclarion Inc (ACONW) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Aclarion Inc (ACONW) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Aclarion Inc (ACON) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Aclarion Inc (ACON) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Aclarion Inc (ACON) Institutional Confidence - TradingKey
Aclarion Inc (ACON) Valuation: PE, PB & Fair Value Analysis - TradingKey
Aclarion Inc (ACON) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Aclarion Inc (ACON) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Aclarion Inc (ACON) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Aclarion Inc (ACON) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Aclarion Inc (ACON) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Aclarion board rejects Echo Lake’s $4 per share takeover bid By Investing.com - Investing.com Nigeria
Aclarion Inc. (ACON) Q1 2026 Earnings: EPS Surpasses Estimates Despite Ongoing Revenue AbsenceEarnings Season Outlook - newsline.com
Aclarion Inc. (ACON) Slides Amid Light Trading, Support at $2.96 in FocusTRIN Signal - newsline.com
Aclarion (ACON) Chief Strategy Officer granted 55,000 RSUs vesting in 2027 - Stock Titan
Aclarion (ACON) director receives 20,000 RSUs vesting in 2027 - Stock Titan
Aclarion (NASDAQ: ACON) director receives 20,000 RSU equity grant - Stock Titan
Aclarion (ACON) CFO awarded 50,000 restricted stock units set to vest 2027 - Stock Titan
Aclarion (ACON) CEO Brent Ness receives 100,000 RSU equity award - Stock Titan
Aclarion (ACON) director awarded 20,000 RSUs vesting in 2027 - Stock Titan
Aclarion (ACON) grants 100,000 RSUs to Executive Chairman Thramann - Stock Titan
Aclarion (ACON) director receives 20,000 RSU equity award, total holdings 22,502 shares - Stock Titan
Director granted 20,000 RSUs at Aclarion (NASDAQ: ACON) vesting 2027 - Stock Titan
ACON Q1 2026 Earnings: EPS Beats Estimates Despite No Revenue ReportedMargin Expansion Trends - newsline.com
ACONW Warrants Surge Over 10%: A Closer Look at the Microcap MoveValue Area High - newsline.com
Aclarion Partners with PRIA Healthcare to Advance Reimbursement and Commercial Adoption of Its AI-Powered Nociscan Platform - Ortho Spine News
Aclarion Inc. (ACON) Consolidates Near Key Support After Marginal DeclinePrice Target - newsline.com
Aclarion to Present at the Planet MicroCap Las Vegas Powered by MicroCapClub - The Manila Times
Triple-digit Nociscan growth as Aclarion presents back-pain tech in Vegas - Stock Titan
Aclarion Company Profile & Introduction - Moomoo
Aclarion partners with PRIA Healthcare on market access program By Investing.com - Investing.com South Africa
Aclarion partners with PRIA Healthcare on market access program - Investing.com
Aclarion enlists PRIA in push for insurer coverage of AI back-pain scans - Stock Titan
Aclarion Inc. Q1 2026 Earnings: EPS Surprises to the Upside Amid Cost DisciplineRevenue Estimate Trend - dars.gov.et
Aclarion waves off investor’s acquisition offer - BizWest
Echo Lake Capital cancelled the acquisition of Aclarion, Inc.. - marketscreener.com
Aclarion Comments on Echo Lake News - Baystreet.ca
ACON Q1 2026 Earnings: Narrower Loss Beats Estimates, Shares Edge HigherShare Repurchase Impact - newsline.com
Aclarion board rejects Echo Lake’s $4 per share takeover bid - Investing.com
1.43%
1.65%
자본화:
|
볼륨(24시간):